Literature DB >> 23886157

MicroRNA-451 inhibits growth of human colorectal carcinoma cells via downregulation of Pi3k/Akt pathway.

Hong-Yan Li1, Yan Zhang, Jian-Hui Cai, Hong-Lei Bian.   

Abstract

MicroRNAs (MiRNAs) play important roles in coordinating a variety of cellular processes and abnormal expression has been linked to the occurrence of several cancers. The miRNA miR-451 is downregulated in colorectal carcinoma (CRC) cells, suggested by several research groups including our own. In this study, synthetic miR-451 mimics were transfected into the SW620 human CRC cell line using Lipofectamine 2000 and expression of miR-451 was analyzed by real time PCR, while expression of CAB39, LKB1, AMPK, AKT, PI3K and Bcl2 was analyzed by Western blot, and cell growth was detected by MTT assay. In comparison to the controls, a significant increase in the expression of miR-451 was associated with significantly decreased expression of CAB39, LKB1, AMPK, AKT, PI3K and Bcl2. The capacity of cell proliferation was significantly decreased by miR-451 expression, which also inhibited cell growth. Our study confirmed that miR-451 has a repressive role in CRC cells by inhibiting cell growth through down-regulating the P13K/AKT pathway.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23886157     DOI: 10.7314/apjcp.2013.14.6.3631

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  27 in total

1.  MicroRNA screening identifies circulating microRNAs as potential biomarkers for osteosarcoma.

Authors:  Hui Li; Kun Zhang; Li-Hong Liu; Yurong Ouyang; Hong-Bin Guo; Hanchong Zhang; Jie Bu; Tao Xiao
Journal:  Oncol Lett       Date:  2015-06-16       Impact factor: 2.967

2.  Circulating microRNA-125b and microRNA-130a expression profiles predict chemoresistance to R-CHOP in diffuse large B-cell lymphoma patients.

Authors:  Wang Xin Yuan; Yang Xi Gui; Wang Na Na; Jiang Chao; Xigui Yang
Journal:  Oncol Lett       Date:  2015-11-05       Impact factor: 2.967

3.  Systemic inhibition of miR-451 increases fibrotic signaling and diminishes autophagic response to exacerbate renal damage in Tallyho/Jng mice.

Authors:  Maurice B Fluitt; Narayan Shivapurkar; Manju Kumari; Sarojini Singh; Lijun Li; Swasti Tiwari; Carolyn M Ecelbarger
Journal:  Am J Physiol Renal Physiol       Date:  2020-07-27

Review 4.  Toward the promise of microRNAs - Enhancing reproducibility and rigor in microRNA research.

Authors:  Kenneth W Witwer; Marc K Halushka
Journal:  RNA Biol       Date:  2016-09-19       Impact factor: 4.652

5.  MiR-451, a potential prognostic biomarker and tumor suppressor for gastric cancer.

Authors:  Zhongxue Su; Juan Zhao; Zhonghou Rong; Wenmao Geng; Zhiyi Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

6.  KIF2A overexpression and its association with clinicopathologic characteristics and unfavorable prognosis in colorectal cancer.

Authors:  Xiangjun Fan; Xudong Wang; Huijun Zhu; Wei Wang; Shu Zhang; Zhiwei Wang
Journal:  Tumour Biol       Date:  2015-06-13

7.  Swimming prevents nonalcoholic fatty liver disease by reducing migration inhibitory factor through Akt suppression and autophagy activation.

Authors:  Haiying Tang; Xiaoyan Tan; Lei Zhu; Kairong Qin; Huan Gao; Hao Bai
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

8.  Novel Association of miR-451 with the Incidence of TEVG Stenosis in a Murine Model.

Authors:  Narutoshi Hibino; Cameron A Best; Alyson Engle; Svetlana Ghimbovschi; Susan Knoblach; Dilip S Nath; Nobuyuki Ishibashi; Richard A Jonas
Journal:  Tissue Eng Part A       Date:  2015-12-17       Impact factor: 3.845

9.  MicroRNA-451 sensitizes lung cancer cells to cisplatin through regulation of Mcl-1.

Authors:  Dezhi Cheng; Yi Xu; Changzheng Sun; Zhifeng He
Journal:  Mol Cell Biochem       Date:  2016-09-30       Impact factor: 3.396

10.  microRNA-451 inhibited cell proliferation, migration and invasion through regulation of MIF in renal cell carcinoma.

Authors:  Yan Tang; Wei Wan; Lijuan Wang; Shishun Ji; Juanjuan Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.